Clinical trial
Sandostatin LAR Depot vs. Surgery for Treating Acromegaly
NCT00001860 · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH · Completed
Key facts
| NCT number | NCT00001860 |
|---|---|
| Title | Sandostatin LAR Depot vs. Surgery for Treating Acromegaly |
| Official title | Sandostatin LAR vs. Surgery in Acromegalics With Macroadenoma |
| Lead sponsor | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acromegaly, Pituitary Neoplasm |
| Intervention type | Drug |
| Interventions | Sandostatin LAR Depot versus transsphenoidal surgery |
| Enrollment | 5 |
| Start date | Aug 1, 1999 |
| Completion | Jul 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: